Digital health, artificial intelligence and machine learning, and precision medicine are the areas where there is the most excitement in innovations for cardiovascular care, said John Rumsfeld, MD, PhD, chief innovation officer at the American College of Cardiology.
Digital health, artificial intelligence and machine learning, and precision medicine are the areas where there is the most excitement in innovations for cardiovascular care, said John Rumsfeld, MD, PhD, chief innovation officer at the American College of Cardiology.
Transcript (slightly modified)
What evolving technologies in cardiology are you expecting to see make big improvements in care?
When we think about innovations coming to cardiovascular care, and specifically transformation of care delivery, I think the areas where there is the most excitement is in digital health, artificial intelligence and machine learning, and precision health or precision medicine. Now, those cross over with each other, but when I talk about those I’m really talking about things like mobile health, wearable sensors, and then using new data sources, which may include genomics, but also other data sources, like social network data, to have a better sense of predicting risk and then combining those digital health tools with the analytics to have more precise care for patients to keep patients healthier, with a focus on health rather than disease, and a focus on care outside the hospital. All of that is a little bit general, but what I think is, is that we are just at the beginning of the digital health transformation.
Healthcare started off in kind of tough way because the first digital healthcare transformation was the electronic health record, which for many clinicians and others has been a frustrating experience and has not been adopted as a new medical device might be for a procedure. Well, they were not really designed to be good in terms of digital transformation. They don’t make things easier or more efficient except from a billing code standpoint, for the most part. They will evolve, but what we really hope will evolve is how we are going to integrate new digital health tools, wearable sensors, and so forth, into our care. It’s still unclear how that’s going to happen because right now there’s a lot of consumer products and there are some products being sold at the health system level. But, what hasn’t happened enough yet is the design and development of digital health tools, specifically to help the interface between patients and their families, and clinicians.
New TROPiCS-02 Data Back Sacituzumab Govitecan for Older Patients With Breast Cancer
December 9th 2023This phase 3 study investigated sacituzumab govitecan, a Trop-2–directed antibody-drug conjugate, vs treatment of physician’s choice in pretreated patients who have endocrine-resistant hormone receptor–positive/HER2-negative breast cancer, the most common form of breast cancer.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Dr Kathryn Lindley on Pregnancy-Related Cardiovascular Care Gaps and Training Initiatives
December 8th 2023Cardiologists need skills in risk assessment, contraception counseling, and hypertension management for pregnant patients, according to Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Refining Precision Prevention for Benign Breast Disease
December 7th 2023Many questions remain surrounding accurately classifying the risk of developing invasive breast cancer associated with the benign breast disease diagnoses of nonproliferative lesions and proliferative changes without atypia.
Read More
Exagamglogene Autotemcel Meets End Points in Severe Sickle Cell Disease, β-Thalassemia
December 7th 2023Two posters set to be presented at the 65th American Society of Hematology Annual Meeting & Exposition met their primary and secondary end points regarding exagamglogene autotemcel therapy for sickle cell disease and β-thalassemia.
Read More